The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
